New York : Researchers have identified a new group of powerful Ebola-fighting antibodies from the blood of a survivor of the 2014 outbreak of the deadly disease, reports IANS.
Because these are human antibodies, not modified mouse antibodies, researchers could quickly use them to a develop a vaccine or therapeutic against Ebola. “Our paper describes the first in-depth view into the human antibody response to Ebola virus,” said study team leader Laura Walker, senior scientist at Adimab, a New Hampshire -based biotechnology company in the US.
Remarkably, 77 percent of the 300 antibodies in the new study showed the potential to neutralise Ebola virus, and several antibodies demonstrated significant protection against the virus in mouse models.
